Pfizer climbs as talks on merger with Allergan advances

The stock opened higher at Rs. 2,426.75 as against its previous close of Rs. 2,420.75. Report suggest's that Pfizer Inc,the parent company, is in advanced talks to buy Allergan for as much as US$ 380 per share

Stock of Pfizer Ltd is currently trading 0.89% higher at Rs. 2,442.35 on BSE on reports about Pfizer Inc., the parent company, is in advanced talks to buy Allergan for as much as US$ 380 per share, valuing the Botox maker at as high as $150 billion in what would be the drug industry’s largest ever deal.

The stock opened higher at Rs. 2,426.75 as against its previous close of Rs. 2,420.75. It hit a high and a low of Rs. 2,450 and Rs. 2,413.05 respectively. So far, total 23,871 shares (BSE+NSE) have changed hands.

The scrip opened at Rs. 2426.75 and has touched a high and low of Rs. 2450 and Rs. 2413.05 respectively. So far 24070 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 11074.38 crore.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2724 on 22-Sep-2015 and a 52 week low of Rs. 1646.2 on 25-Nov-2014. Last one week high and low of the scrip stood at Rs. 2475 and Rs. 2361.6 respectively.

The promoters holding in the company stood at 63.92 % while Institutions and Non-Institutions held 12.89 % and 23.18 % respectively.

The stock is currently trading above its 50 DMA.